I INSM
Insmed Inc
BIOTECHNOLOGY · HEALTHCARE
Insmed Inc. is a biopharmaceutical company based in Bridgewater, New Jersey, that specializes in developing innovative therapies for patients with rare and serious diseases, particularly in the realms of pulmonary and infectious diseases. The company's lead product, ARIKAYCE, offers a vital treatmen...
$97.85
+1.17% (+$1.13)
Volume
4.53M
52W High
$212.75
52W Low
$90.39
Market Cap
$29.59B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.77
Whisper EPS
-$0.77
0.2% above consensus
Last Quarter
-$0.76
Current Streak
2 Beats
Avg Surprise (4Q)
+3.56%
Next Earnings Report
Reports in 52 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 7, 2026
1-Day:
-3.48%
5-Day:
+10.48%
Q1 2026
Apr 30, 2026
1-Day:
-2.25%
5-Day:
+2.28%
Q4 2025
Feb 19, 2026
1-Day:
+2.43%
5-Day:
-1.48%
Q3 2025
Oct 30, 2025
1-Day:
-2.38%
5-Day:
-5.90%
Revenue & Financial Performance
Revenue Whisper
$194.0M
TWN Proprietary Estimate
Last Quarter Revenue
$306.0M
+229.6% YoY
Gross Margin
83.8%
Net Margin: -53.5%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $306.0M | +229.6% | 83.8% | -65.5% | -$163.6M |
| Q4'25 | $263.8M | +152.6% | 83.2% | -94.6% | -$328.5M |
| Q3'25 | $142.3M | +52.4% | 79.4% | -257.1% | -$370.0M |
| Q2'25 | $107.4M | +18.9% | 73.9% | -291.3% | -$321.7M |
| Q1'25 | $92.8M | +22.9% | 77.1% | -267.3% | -$256.6M |
| Q4'24 | $104.4M | +24.8% | 75.0% | -220.6% | -$235.5M |
| Q3'24 | $93.4M | +18.2% | 77.3% | -228.5% | -$220.5M |
| Q2'24 | $90.3M | +17.0% | 76.8% | -319.8% | -$300.6M |
Company Information
Symbol
INSM
Company
Insmed Inc
Market Cap
$29.59B
Sector
HEALTHCARE
Next Earnings
Aug 6, 2026
Also Reporting Soon
Companies reporting earnings around the same time as INSM
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare INSM with competitors
Side-by-side earnings comparison